{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:36:21Z","timestamp":1782311781469,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clbc.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:12:57Z","timestamp":1700255577000},"page":"e126-e137.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study"],"prefix":"10.1016","volume":"24","author":[{"given":"Hanzhao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-1258","authenticated-orcid":false,"given":"Zhenzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clbc.2023.11.004_bib0001","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0959-8049(01)00067-3","article-title":"Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer","volume":"37","author":"Ververs","year":"2001","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.004_bib0002","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2023.11.004_bib0003","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.004_bib0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.clbc.2023.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.004_bib0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow-up result of the OTOASOR trial: the optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.004_bib0007","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomized, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2023.11.004_bib0008","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002440","article-title":"Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS Era","volume":"268","author":"Poodt","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2023.11.004_bib0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jss.2020.05.073","article-title":"National trend of axillary management in clinical T3\/T4 N0 patients having breast conserving therapy","volume":"255","author":"Morris","year":"2020","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cncr.23514","article-title":"How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?","volume":"113","author":"Yi","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2023.11.004_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.004_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy","volume":"24","author":"FitzSullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.004_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-020-05876-z","article-title":"Analyzing non-sentinel axillary metastases in patients with T3\u2013T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy","volume":"184","author":"Riedel","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.clbc.2023.11.004_bib0014","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejso.2008.10.003","article-title":"A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis","volume":"35","author":"Houvenaeghel","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2023.11.004_bib0015","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1245\/s10434-018-6409-6","article-title":"Axillary surgery for early-stage, node-positive mastectomy patients and the use of postmastectomy chest wall radiation therapy","volume":"25","author":"Gaines","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.004_bib0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-019-05327-4","article-title":"Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort","volume":"177","author":"Riedel","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-019-05520-5","article-title":"Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy","volume":"180","author":"Tadros","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clbc.2023.11.004_bib0018","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clbc.2013.04.004","article-title":"Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?","volume":"13","author":"S\u00e1volt","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.004_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjsurg.2015.05.004","article-title":"Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients","volume":"210","author":"Snow","year":"2015","journal-title":"Am J Surg"},{"issue":"11","key":"10.1016\/j.clbc.2023.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.ejso.2018.07.005","article-title":"The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer","volume":"44","author":"Poodt","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","article-title":"Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer","volume":"221","author":"Yao","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"21","key":"10.1016\/j.clbc.2023.11.004_bib0022","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.004_bib0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SAP.0b013e3182605598","article-title":"A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique","volume":"72","author":"Losken","year":"2014","journal-title":"Ann Plast Surg"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.004_bib0024","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2023.11.004_bib0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ejso.2015.04.003","article-title":"Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes","volume":"41","author":"Bonneau","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.004_bib0026","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4143\/crt.2018.438","article-title":"Axillary lymph node dissection does not improve post-mastectomy overall or disease-free survival among breast cancer patients with 1-3 positive nodes","volume":"51","author":"Joo","year":"2019","journal-title":"Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.clbc.2023.11.004_bib0027","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/bjs\/znac305","article-title":"Axillary lymph node dissection can be safely omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis","volume":"109","author":"Cocco","year":"2022","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.clbc.2023.11.004_bib0028","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1245\/s10434-019-07388-7","article-title":"Evolution of the use of completion axillary lymph node dissection in patients with T1\/2N0M0 breast cancer and tumour-involved sentinel lymph nodes undergoing mastectomy: a cohort study","volume":"26","author":"Hennigs","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.004_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-019-05243-7","article-title":"Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes","volume":"176","author":"Weiss","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.6004\/jnccn.2020.7597","article-title":"Impact of axillary dissection among patients with sentinel node-positive breast cancer undergoing mastectomy","volume":"19","author":"Sun","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-022-06727-9","article-title":"Axilla lymph node dissection can be safely omitted in patients with 1\u20132 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis","volume":"196","author":"Gao","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.clbc.2023.11.004_bib0032","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1245\/s10434-012-2386-3","article-title":"Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment","volume":"19","author":"Milgrom","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.11.004_bib0033","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1093\/oncolo\/oyad038","article-title":"Survival after sentinel lymph node biopsy compared with axillary lymph node dissection for female patients with T3-4c breast cancer","volume":"28","author":"Li","year":"2023","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-021-06290-9","article-title":"National trends for axillary lymph node dissection and survival outcomes for clinical T3\/T4 node-negative breast cancer patients undergoing mastectomy with positive lymph nodes","volume":"189","author":"Reyna","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-015-0439-8","article-title":"Progress in adjuvant chemotherapy for breast cancer: an overview","volume":"13","author":"Anampa","year":"2015","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.004_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2023.11.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T11:02:51Z","timestamp":1711191771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923002884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1526820923002884"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.11.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}